Luma Vision has won FDA clearance to expand the capabilities of its Verafeye cardiac ablation procedure intelligence platform. The privately held, Dublin, Ireland–based medtech plans to launch commercially in early 2027. The news comes about six months after the company said it was expanding its clinical programs after submitting to the … [Read more...] about Luma Vision wins expanded FDA nod for its cardiac procedure software
Luma Vision
Luma Vision expands clinical program, submits latest Verafeye tech to FDA
Luma Vision announced today that it expanded its clinical program following the latest submission of its Verafeye platform to the FDA. Dublin, Ireland-based Luma Vision develops the Verafeye 4D navigation and imaging platform. The company designed Verafeye to guide catheter ablation therapy. That includes pulmonary vein isolation, posterior wall … [Read more...] about Luma Vision expands clinical program, submits latest Verafeye tech to FDA
Luma Vision, CardioFocus complete 4D-guided AFib ablation procedures in clinical study
Luma Vision announced that it completed 15 AFib ablation procedures as part of a clinical study in collaboration with CardioFocus. Dublin, Ireland-based Luma Vision said the study aims to, in part, evaluate the ability of its Verafeye 4D navigation and imaging platform. The company designed Verafeye to guide catheter ablation therapy. That … [Read more...] about Luma Vision, CardioFocus complete 4D-guided AFib ablation procedures in clinical study
Luma Vision wins FDA clearance for cardiac visualization platform
Luma Vision recently announced that the FDA has cleared its Verafeye catheter-based cardiac imaging system. The company — based in Dublin, Ireland, and Munich, Germany — describes Verafeye as a novel catheter-based imaging system that provides real-time, two and four-dimensional, 360-degree visualization, enhancing clinician precision and … [Read more...] about Luma Vision wins FDA clearance for cardiac visualization platform
